Surgical Treatment of Crohn Colitis Involving More Than 2 Colonic Segments: Long-Term Outcomes From a Single Institution

• Published in: Medicine (Baltimore) Vol. 95; no. 22; p. e3793
• Main Authors: Lee, Jong Lyul, Yu, Chang Sik, Lim, Seok-Byung, Park, In Ja, Yoon, Yong Sik, Kim, Chan Wook, Yang, Suk-Kyun, Kim, Jin Cheon
• Format: Journal Article
• Language: English
• Published: United States Wolters Kluwer Health 01.05.2016
• Subjects: Adult; Age of Onset; Colectomy - methods; Colitis - drug therapy; Colitis - surgery; Crohn Disease - drug therapy; Crohn Disease - surgery; Female; Humans; Immunosuppressive Agents - therapeutic use; Male; Mesalamine - therapeutic use; Nutritional Status; Observational Study; Postoperative Complications - epidemiology; Recurrence; Retrospective Studies; Risk Factors; Survival; Young Adult
• ISSN: 0025-7974; 1536-5964
• DOI: 10.1097/MD.0000000000003793

The incidence of primary Crohn colitis is uncommon and surgical treatment has remained controversial, although most patients with Crohn colitis eventually require surgical intervention. This study aims to compare the operative outcomes of patients who underwent segmental versus either total colectomy or total proctocolectomy for Crohn colitis and to assess potential risk factors associated with clinical and surgical recurrence-free survivals.This is a retrospective study of 116 patients who underwent primary surgery for Crohn colitis between August 1997 and July 2011. Patients were classified based on the type of surgery: segmental colectomy (SC group; n = 71) or either total colectomy or total proctocolectomy (TC group; n = 45).There were no significant differences in postoperative complications or the nutritional state between the SC and TC groups. Patients in TC group had a significantly higher clinical recurrence-free survival (CRFS). Among the 54 patients with multisegmental Crohn colitis, the TC group had a significantly increased CRFS and surgical recurrence-free survival (SRFS), compared with patients in the SC group (5-year CRFS: 82.0% ± 5.8% vs 22.2% ± 13.9%, P = 0.001; 5-year SRFS: 88.1% ± 5.0% vs 44.4% ± 16.6%, P = 0.001). By multivariate analysis of patients with multisegments involved, SC was a risk factor for SRFS and CRFS (hazard ratio [HR] = 4.637, 95% confidence interval [CI] = 1.387-15.509, P = 0.013 and HR = 32.407, 95% CI = 2.873-365.583, P = 0.005).TC patients have significantly increased CRFS and TC in patients with multisegment involvement may affect improved SRFS and CRFS. Among patients with multisegmental Crohn colitis, SC is an independent risk factor for CRFS and SRFS.